Caprock Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.15M Sell
57,813
-9,653
-14% -$744K 0.1% 176
2025
Q4
$5.35M Buy
67,466
+14,264
+27% +$1.12M 0.11% 144
2025
Q3
$3.89M Buy
+53,202
New +$3.65M 0.1% 182
2025
Q1
$2.52M Buy
37,185
+13,159
+55% +$787K 0.08% 231
2024
Q4
$1.08M Sell
24,026
-12,602
-34% -$707K 0.04% 401
2024
Q3
$2.3M Sell
36,628
-1,194
-3% -$69.7K 0.08% 211
2024
Q2
$2.23M Buy
37,822
+8,051
+27% +$504K 0.09% 181
2024
Q1
$2.37M Sell
29,771
-162
-0.5% -$12.4K 0.14% 106
2023
Q4
$2.36M Buy
29,933
+1,885
+7% +$134K 0.15% 106
2023
Q3
$1.96M Sell
28,048
-1,947
-6% -$138K 0.15% 103
2023
Q2
$2.07M Sell
29,995
-3,938
-12% -$280K 0.15% 103
2023
Q1
$2.52M Buy
+33,933
New +$2.85M 0.2% 79
2022
Q4
Sell
-21,233
Closed -$2.02M 570
2022
Q3
$2.02M Buy
21,233
+571
+3% +$56.5K 0.2% 77
2022
Q2
$1.92M Buy
20,662
+582
+3% +$56.8K 0.19% 80
2022
Q1
$2.03M Buy
20,080
+191
+1% +$20.1K 0.19% 86
2021
Q4
$2.05M Buy
19,889
+604
+3% +$55.8K 0.17% 84
2021
Q3
$1.64M Sell
19,285
-1,551
-7% -$130K 0.15% 99
2021
Q2
$1.74M Buy
20,836
+1,100
+6% +$90.1K 0.16% 99
2021
Q1
$1.49M Sell
19,736
-1,896
-9% -$138K 0.16% 104
2020
Q4
$1.48M Buy
21,632
+1,250
+6% +$81.3K 0.17% 102
2020
Q3
$1.19M Sell
20,382
-414
-2% -$25.8K 0.16% 108
2020
Q2
$1.35M Sell
20,796
-196
-0.9% -$12.3K 0.2% 90
2020
Q1
$1.25M Sell
20,992
-1,703
-8% -$114K 0.24% 83
2019
Q4
$1.69M Buy
22,695
+1,190
+6% +$83.6K 0.3% 63
2019
Q3
$1.36M Sell
21,505
-1,177
-5% -$69.7K 0.26% 73
2019
Q2
$1.24M Buy
22,682
+1,300
+6% +$70K 0.24% 81
2019
Q1
$1.15M Buy
21,382
+6,395
+43% +$395K 0.22% 89
2018
Q4
$982K Buy
14,987
+3,365
+29% +$251K 0.23% 93
2018
Q3
$915K Sell
11,622
-427
-4% -$30.5K 0.19% 105
2018
Q2
$775K Sell
12,049
-1,287
-10% -$84.8K 0.16% 117
2018
Q1
$830K Buy
13,336
+86
+0.6% +$6.17K 0.18% 112
2017
Q4
$1.04M Sell
13,250
-535
-4% -$38.9K 0.2% 101
2017
Q3
$1.12M Sell
13,785
-527
-4% -$41.7K 0.23% 78
2017
Q2
$1.15M Buy
14,312
+234
+2% +$18.5K 0.26% 76
2017
Q1
$1.1M Sell
14,078
-502
-3% -$40.1K 0.26% 68
2016
Q4
$1.15M Sell
14,580
-1,441
-9% -$117K 0.29% 71
2016
Q3
$1.43M Buy
16,021
+4,285
+37% +$404K 0.32% 73
2016
Q2
$1.12M Sell
11,736
-518
-4% -$51.6K 0.27% 89
2016
Q1
$1.27M Buy
+12,254
New +$1.19M 0.3% 74

Other funds holding CVS

Caprock Group's CVS Position: Q1 2026 in Review

Caprock Group reduced its CVS Health (CVS) stake by 14% in Q1 2026, selling an estimated $744K and leaving 57,813 shares worth $4.15M. The position accounts for 0.1% of the portfolio, ranked #176.

Caprock Group first reported a position in CVS in Q1 2016 and has held it in 39 quarters since. The position peaked at $5.35M in Q4 2025. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Caprock Group held 57,813 shares of CVS Health worth $4.15M as of Q1 2026.
  • Caprock Group sold 9,653 CVS Health shares in Q1 2026, an estimated $744K.
  • CVS Health made up 0.1% of Caprock Group's portfolio in Q1 2026, its #176 holding.
  • Caprock Group first reported a position in CVS Health in Q1 2016 and has held it in 39 quarters since.
  • Caprock Group's CVS Health position peaked at $5.35M in Q4 2025.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Caprock Group's 13F filing for Q1 2026, filed 11 May 2026.